Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Identification of Plasma Protein Biomarkers and Drug Targets for Hematologic Malignancies by Proteome-wide Mendelian Randomization

Submitted by Anna Hakala on Thu, 10/16/2025 - 10:47
  • Read more about Identification of Plasma Protein Biomarkers and Drug Targets for Hematologic Malignancies by Proteome-wide Mendelian Randomization

Multipopulation GWAS for venous thromboembolism identifies novel loci followed by experimental validation in zebrafish

Submitted by Anna Hakala on Wed, 10/08/2025 - 09:29
  • Read more about Multipopulation GWAS for venous thromboembolism identifies novel loci followed by experimental validation in zebrafish

Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study

Submitted by Anna Hakala on Tue, 10/07/2025 - 10:16
  • Read more about Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study

Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study

Submitted by Anna Hakala on Tue, 10/07/2025 - 10:07
  • Read more about Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study

Genetic evidence for the correlation between relative nutrient intake and male reproductive health: a Mendelian randomized study

Submitted by Anna Hakala on Tue, 10/07/2025 - 10:05
  • Read more about Genetic evidence for the correlation between relative nutrient intake and male reproductive health: a Mendelian randomized study

The relationship between gut microbiota, plasma metabolites, and iron deficiency anemia in European populations: a three-sample Mendelian randomization analysis

Submitted by Anna Hakala on Tue, 10/07/2025 - 10:01
  • Read more about The relationship between gut microbiota, plasma metabolites, and iron deficiency anemia in European populations: a three-sample Mendelian randomization analysis

Triangulation evidence for the causal effect of monocytes on pulmonary artery hypertension: a Mendelian randomization study and results from NHANES

Submitted by Anna Hakala on Tue, 10/07/2025 - 09:57
  • Read more about Triangulation evidence for the causal effect of monocytes on pulmonary artery hypertension: a Mendelian randomization study and results from NHANES

Circulating vitamin D concentrations and the risk of urticaria: A bidirectional two-sample Mendelian randomization study

Submitted by Anna Hakala on Tue, 10/07/2025 - 09:55
  • Read more about Circulating vitamin D concentrations and the risk of urticaria: A bidirectional two-sample Mendelian randomization study

Measures of General Intelligence and Risk for Alcohol Use Disorder

Submitted by Anna Hakala on Tue, 10/07/2025 - 09:46
  • Read more about Measures of General Intelligence and Risk for Alcohol Use Disorder

Decoding the Molecular Landscape of Inflammatory Bowel Disease: A Mendelian Randomization and Machine Learning Analysis

Submitted by Anna Hakala on Tue, 10/07/2025 - 09:44
  • Read more about Decoding the Molecular Landscape of Inflammatory Bowel Disease: A Mendelian Randomization and Machine Learning Analysis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • Current page 99
  • Page 100
  • Page 101
  • Page 102
  • Page 103
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement